Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Down 75.0% in January

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 100 shares, a drop of 75.0% from the December 31st total of 400 shares. Based on an average daily trading volume, of 3,100 shares, the short-interest ratio is presently 0.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Up 0.5 %

Harrow Health, Inc. 11.875% Senior Notes due 2027 stock traded up $0.13 during mid-day trading on Wednesday, reaching $26.58. 104 shares of the stock traded hands, compared to its average volume of 4,151. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 12-month low of $25.30 and a 12-month high of $27.72. The business’s 50-day moving average is $26.35 and its 200-day moving average is $26.36.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Wednesday, January 15th will be given a dividend of $0.7422 per share. The ex-dividend date is Wednesday, January 15th. This represents a $2.97 dividend on an annualized basis and a dividend yield of 11.17%.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.